INVESTOR

Home > Information Disclosure > Full Article

IASO Bio Appoints Dr. David He as Chief Technology Officer and Executive Vice President

2021.07.10 | IASO,IASO Bio,IASO Biotherapeutics,IASO Biopharma,CT103A, CAR-T, cell therapy,dual-targeted CAR-T
Back

📎 Attachment Download:

 
Back